Trans American Aquaculture (GRPS) Short-Term Debt issuances (2023 - 2025)
Trans American Aquaculture (GRPS) reported Short-Term Debt issuances of -$1000.0 for Q1 2025, down 247.22% quarter-over-quarter from -$288.0 in Q1 2023.
Trans American Aquaculture (GRPS) Short-Term Debt issuances (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Short-Term Debt issuances for 2 years, with the latest figure at -$1000.0 in Q1 2025.
- For the quarter ending Q1 2025, Short-Term Debt issuances changed N/A year-over-year to -$1000.0; the trailing twelve-month figure through Sep 2025 stood at -$1000.0 (changed N/A YoY), and the FY2023 full-year result was -$288.0, up 92.57% from the prior year.
- Short-Term Debt issuances for Q1 2025 stood at -$1000.0, down from -$288.0 in the prior quarter.
- The five-year high for Short-Term Debt issuances was -$288.0 in Q1 2023, with the low at -$1000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2023 | -288.00 |
| Mar 31, 2023 | -288.00 |